p applicant Lilly 
The Pharma Data
JULY 29, 2021
P-tau217 in blood showed promise as additional biomarker of efficacy- Donanemab treatment led to 24% lowering of P-tau217 from baseline. In June 2021, Lilly announced the U.S. . vice president of pain and neurodegeneration, Lilly.
pharmaphorum
OCTOBER 27, 2021
Eli Lilly has followed through on its plan to file for approval of its Alzheimer’s disease candidate donanemab, and is planning to take on Biogen and Eisai with a head-to-head trial against their recently-approved Aduhelm drug.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
NOVEMBER 10, 2020
Although a few are out there, phosphorylated tau (P-tau) may enable even earlier and more accurate detection, according to Eli Lilly-associated researchers speaking at the Clinical Trials on Alzheimer’s Disease (CTAD) virtual conference in early November. Therefore, Eli Lilly is developing an assay that measures P-tau 217 in blood.
Pharma in Brief
MARCH 18, 2021
collectively, Apotex ) brought an action in the Ontario Superior Court seeking damages against Eli Lilly Canada Inc. and its related companies (collectively, Lilly ) under the Statutes of Monopolies , [1] the Trademarks Act , [2] and the common law tort of conspiracy. Procedural Background . Apotex Inc. and Apotex Pharmachem Inc.
pharmaphorum
SEPTEMBER 16, 2022
Having been in development by Almirall and Eli Lilly and Company for moderate to severe AD, recent findings from a phase 3 trial for the first time have shown year-long (52-week) management of symptoms, in comparison with short-term 16-week maintenance of previous trials. The 16-week data was made public in March of this year.
The Pharma Data
NOVEMBER 9, 2020
Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for Eli Lilly and Company’s (NYSE: LLY) investigational neutralizing antibody bamlanivimab (LY-CoV555) 700 mg. Ricks, Lilly’s chairman and CEO. Lilly’s chief scientific officer and president of Lilly Research Laboratories.
Roots Analysis
OCTOBER 19, 2023
Following this, in the 1940s, Eli Lilly became the first company to produce phages for human use in the US. Applications of Bacteriophage Therapy Bacteriophages can be employed in various biotechnological applications, including food–animal agriculture, aquaculture, human and veterinary medicine, and environmental science.
Expert insights. Personalized for you.
52 
Let's personalize your content